Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Capital Expenditures: 2009-2022

Historic Capital Expenditures for Avadel Pharmaceuticals (AVDL) over the last 14 years, with Dec 2022 value amounting to $716,000.

  • Avadel Pharmaceuticals' Capital Expenditures was N/A to $716,000 in Q3 2022 from the same period last year, while for Sep 2022 it was $840,000, marking a year-over-year change of. This contributed to the annual value of $716,000 for FY2022, which is 2653.85% up from last year.
  • Latest data reveals that Avadel Pharmaceuticals reported Capital Expenditures of $716,000 as of FY2022, which was up 2,653.85% from $26,000 recorded in FY2021.
  • Over the past 5 years, Avadel Pharmaceuticals' Capital Expenditures peaked at $716,000 during FY2022, and registered a low of $26,000 during FY2021.
  • Its 3-year average for Capital Expenditures is $280,000, with a median of $98,000 in 2020.
  • Per our database at Business Quant, Avadel Pharmaceuticals' Capital Expenditures crashed by 83.71% in 2019 and then surged by 2,653.85% in 2022.
  • Over the past 5 years, Avadel Pharmaceuticals' Capital Expenditures (Yearly) stood at $178,000 in 2018, then slumped by 83.71% to $29,000 in 2019, then spiked by 237.93% to $98,000 in 2020, then slumped by 73.47% to $26,000 in 2021, then surged by 2,653.85% to $716,000 in 2022.